LCM
ABOS icon

Laurion Capital Management’s Acumen Pharmaceuticals ABOS Stock Holding History

Laurion Capital Management’s Portfolio ABOS Stock Details ABOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.24M Sell
525,444
-341,602
-39% -$871K 0.05% 246
2025
Q4 		$1.83M Hold
867,046
– – 0.07% 107
2025
Q3 		$1.48M Hold
867,046
– – 0.03% 173
2025
Q2 		$1.01M Hold
867,046
– – 0.02% 208
2025
Q1 		$954K Hold
867,046
– – 0.02% 175
2024
Q4 		$1.49M Hold
867,046
– – 0.03% 194
2024
Q3 		$2.15M Sell
867,046
-311,292
-26% -$844K 0.03% 153
2024
Q2 		$2.85M Sell
1,178,338
-716,685
-38% -$2.28M 0.03% 191
2024
Q1 		$7.67M Hold
1,895,023
– – 0.07% 217
2023
Q4 		$7.28M Hold
1,895,023
– – 0.06% 216
2023
Q3 		$7.86M Buy
1,895,023
+688,475
+57% +$4.25M 0.05% 236
2023
Q2 		$5.8M Hold
1,206,548
– – 0.03% 252
2023
Q1 		$4.9M Hold
1,206,548
– – 0.03% 238
2022
Q4 		$6.52M Hold
1,206,548
– – 0.03% 253
2022
Q3 		$12.1M Hold
1,206,548
– – 0.07% 175
2022
Q2 		$5.67M Buy
1,206,548
+549,700
+84% +$2.07M 0.09% 147
2022
Q1 		$2.57M Hold
656,848
– – 0.03% 199
2021
Q4 		$4.44M Hold
656,848
– – 0.04% 205
2021
Q3 		$9.76M Buy
+656,848
New +$10.9M 0.04% 277

Other funds holding ABOS

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $421M AUM 26.25% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
KIA
Knollwood Investment Advisory Hunt Valley, Maryland $992M AUM 28.95% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

Laurion Capital Management's ABOS Position: Q1 2026 in Review

Laurion Capital Management reduced its Acumen Pharmaceuticals (ABOS) stake by 39% in Q1 2026, selling an estimated $871K and leaving 525,444 shares worth $1.24M. The position accounts for 0.05% of the portfolio, ranked #246.

Laurion Capital Management first reported a position in ABOS in Q3 2021 and has held it in 19 quarters since. The position peaked at $12.1M in Q3 2022. 84 funds tracked by Wall St. Rank hold ABOS as of Q1 2026.

  • Laurion Capital Management held 525,444 shares of Acumen Pharmaceuticals worth $1.24M as of Q1 2026.
  • Laurion Capital Management sold 341,602 Acumen Pharmaceuticals shares in Q1 2026, an estimated $871K.
  • Acumen Pharmaceuticals made up 0.05% of Laurion Capital Management's portfolio in Q1 2026, its #246 holding.
  • Laurion Capital Management first reported a position in Acumen Pharmaceuticals in Q3 2021 and has held it in 19 quarters since.
  • Laurion Capital Management's Acumen Pharmaceuticals position peaked at $12.1M in Q3 2022.
  • 84 funds tracked by Wall St. Rank held Acumen Pharmaceuticals as of Q1 2026.

Based on Laurion Capital Management's 13F filing for Q1 2026, filed 14 May 2026.